Leaders in Regulatory Affairs for the Medical Device Industry

Monthly Archives: June 2017

PaxMed Announces the FDA Clearance of ReBOSSIS85

For Immediate Release, June 23, 2017: PaxMed International, LLC announces, on behalf of Orthorebirth Co., Ltd. of Yokohama, Japan, the 510(k) clearance of ReBOSSIS85, synthetic, resorbable bone void filler. It is a composite material consisting of (by weight) 40% beta-tricalcium phosphate (β-TCP), 30% siloxane-containing vaterite (a form of calcium carbonate, CaCO3), and 30% poly(L-lactide-co-glycolide). The […]

Read More